Novo Nordisk Stock Today, 28 November 2025: Goldman Sachs Trims Target as Obesity Pipeline Fights Back
Novo Nordisk (NYSE: NVO) shares are trying to stabilise after a bruising November as fresh obesity‑drug data, a higher‑dose Wegovy filing and new analyst calls collide with lingering worries about growth and competition. 1. How Novo Nordisk stock is trading today Novo Nordisk’s U.S.-listed ADRs are changing hands around $49.25, up roughly 1% on the day, after trading between $48.35 and $49.75 in Friday’s session. Intraday volume is a little over 6.7 million shares, in line with recent elevated activity. On its home market in Copenhagen, Novo’s B‑shares closed near 317 DKK, up about 2% on the day but still down roughly 49% year to date, according to MarketScreener data. MarketScreener Even after today’s